Cogent Biosciences Gains 1.66% on April 21, Surpassing 200‑Day SMA Amid Volatile Biotech Market
Cogent Biosciences (COGT) rises 1.66% to $31.24, trading above its 200‑day average despite a month‑end decline; investors watch pipeline progress and regulatory milestones.
- COGENT BIOSCIENCES INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read